Merck & Co. Inc. (MRK)
|
41.155
+0.155 (+0.38%)
|
|
|
|
MRK additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
MRK Profile
•
Exchange
NYSE
•
Top Holders (By Fund)
American Funds Washington Mutual R4
American Funds Washington Mutual R2
American Funds Washington Mutual R1
American Funds Washington Mutual F-1
American Funds Washington Mutual B
American Funds Washington Mutual A
American Funds Washington Mutual 529F
American Funds Washington Mutual 529E
American Funds Washington Mutual 529C
American Funds Washington Mutual 529B
American Funds Washington Mutual R2
American Funds Washington Mutual R1
American Funds Washington Mutual F-1
American Funds Washington Mutual B
American Funds Washington Mutual A
American Funds Washington Mutual 529F
American Funds Washington Mutual 529E
American Funds Washington Mutual 529C
American Funds Washington Mutual 529B
•
Top Holders (By Family)
•
Executives
Mr. Kenneth C. Frazier
Chairman
Chief Exec. Officer and Pres
Mr. Peter N. Kellogg
Chief Financial Officer and Exec. VP
Dr. Peter S. Kim Ph.D.
Exec. VP and Pres of Merck Research Laboratories
Mr. Adam H. Schechter
Exec. VP and Pres of Global Human Health
Mr. Bruce N. Kuhlik
Exec. VP and Gen. Counsel
Chairman
Chief Exec. Officer and Pres
Mr. Peter N. Kellogg
Chief Financial Officer and Exec. VP
Dr. Peter S. Kim Ph.D.
Exec. VP and Pres of Merck Research Laboratories
Mr. Adam H. Schechter
Exec. VP and Pres of Global Human Health
Mr. Bruce N. Kuhlik
Exec. VP and Gen. Counsel
•
Employee Count
86,000
Special Offers
Competitors
MRK earnings
Date
Actual
Expected
Prev Yr Qtr
2/1/2013
0.83
0.81
0.97
10/26/2012
0.95
0.92
0.94
7/27/2012
1.05
1.01
0.95
